CELLPROTHERA
LIVE

Serial Number

79076423

Owner

CELLPROTHERA

Attorney

Jonathan Myers

Filing Date

Jul 31, 2009

Add to watchlist:

No watchlists yet
View on USPTO

CELLPROTHERA Trademark

Serial Number: 79076423 • Registration: 3980163

CELLPROTHERA is a trademark filed by CELLPROTHERA on July 31, 2009. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

CELLPROTHERA (10 trademarks)

12 rue du Parc
68100 Mulhouse - , FR

Entity Type: 99

Trademark Details

Filing Date

July 31, 2009

Registration Date

June 21, 2011

Published for Opposition

April 5, 2011

Cancellation Date

August 1, 2019

Goods & Services

Biological preparations for cell cultures; cell culture media, namely, culture media for endothelial and myocardiac cells; culture media for cell growth for medical biotechnology, namely,culture media for growing and regenerating endothelial and myocardiac cells; biological reagents for molecular biology; chemical reagents for medical use for biological processes; carriers of culture media for medical use, namely, Iscove's modified Dulbecco's medium, used for rapidly proliferating high density cell cultures; cellular function activating agents, namely,cell growth factors, hematopoietic factors, serums, namely, human and animal serums for cell culture; antibodies, namely, monoclonal antibodies for detection and treatment of pathologies; all these products being for medical use

Medical care and treatment; medical services for cell sampling and isolation, namely, leukapheresis medical treatment services; services for medical analysis relating to treating individuals, namely, behavior analysis for medical purposes; therapeutic treatment, namely, cell therapy for regenerative medicine

Medical apparatus and instruments, namely, intravascular cell reinjection catheters; apparatus for human cell culture, namely, medical device for providing human cell culture diagnosis and treatment; cell analyzers for medical treatment and diagnostic use; medical device for production of human cell grafts, namely, medical device allowing in vitro stem cell expansion for therapeutic use; instruments for cell culture, namely, medical instruments used for cell culture diagnosis and treatment; medical device for human cell selection, namely, medical device for human cell immune selection used for diagnosis and treatment

Research and development of new products in the field of biotechnology; services for scientific analysis for medical purposes, namely, medical research laboratory services; development of new products for medical research for third parties

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
May 30, 2022 FINO
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Oct 29, 2021 OPNX
NOTIFICATION PROCESSED BY IB
Sep 4, 2021 GPNX
REFUSAL PROCESSED BY IB
Aug 29, 2020 RFNT
NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Feb 21, 2020 DENC
DEATH OF INTERNATIONAL REGISTRATION
Feb 21, 2020 DETH
CHANGE OF NAME/ADDRESS REC'D FROM IB
Aug 22, 2019 ADCH
NEW REPRESENTATIVE AT IB RECEIVED
Aug 1, 2019 NREP
TOTAL INVALIDATION PROCESSED BY THE IB
Dec 14, 2018 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Sep 27, 2018 INTS
INVALIDATION PROCESSED
Sep 27, 2018 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Sep 26, 2018 INTR
CANCELLED SECTION 71
Jan 26, 2018 C71T
FINAL DECISION TRANSACTION PROCESSED BY IB
May 14, 2013 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Nov 17, 2011 FICS
FINAL DISPOSITION PROCESSED
Nov 17, 2011 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 21, 2011 FICR
REGISTERED-PRINCIPAL REGISTER
Jun 21, 2011 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jun 11, 2011 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 25, 2011 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
May 25, 2011 OPNR
PUBLISHED FOR OPPOSITION
Apr 5, 2011 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 17, 2011 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Mar 17, 2011 OP2R
NOTICE OF PUBLICATION
Mar 16, 2011 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Mar 2, 2011 PREV
ASSIGNED TO LIE
Mar 2, 2011 ALIE
ASSIGNED TO LIE
Feb 2, 2011 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 31, 2011 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 24, 2011 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 24, 2011 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jan 24, 2011 ERFR
FINAL REFUSAL MAILED
Aug 11, 2010 CNFR
FINAL REFUSAL WRITTEN
Aug 10, 2010 CNFR
DATA MODIFICATION COMPLETED
Aug 10, 2010 DMCC
AMENDMENT FROM APPLICANT ENTERED
Jul 20, 2010 ACEC
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 20, 2010 CRFA
ASSIGNED TO LIE
Jul 17, 2010 ALIE
PAPER RECEIVED
Jul 6, 2010 MAIL
REFUSAL PROCESSED BY IB
Jan 29, 2010 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 6, 2010 RFCS
REFUSAL PROCESSED BY MPU
Jan 6, 2010 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 6, 2010 RFCR
NON-FINAL ACTION WRITTEN
Jan 5, 2010 CNRT
APPLICATION FILING RECEIPT MAILED
Jan 2, 2010 MAFR
ASSIGNED TO EXAMINER
Dec 29, 2009 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 29, 2009 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 24, 2009 REPR